(HealthDay)—An experimental drug that taps the power of the
body's immune system to fight cancer is shrinking tumors in
patients for whom other treatments have failed, an early study
shows. Cancer May 16, 2013 | 5 / 5 (3) | 0 | Kidney cancer is a
type of cancer that starts in the cells in the kidney. The two
most common types of kidney cancer are renal cell carcinoma
(RCC) and urothelial cell carcinoma (UCC) of the renal pelvis.
These names reflect the type of cell from which the cancer
developed. The different types of kidney cancer (such as RCC and
UCC) develop in different ways, meaning that the diseases have
different outlooks (or prognosis), and need to be staged and
treated in different ways. This text uses material from
Wikipedia and is available under the GNU Free Documentation
License. Latest Spotlight News Researchers at the University of
Wisconsin have identified a potential new risk factor for
obstructive sleep apnea: asthma. Using data from the National
Institutes of Health (Heart, Lung, and Bloo